Cellectar Biosciences Files 8-K
Ticker: CLRB · Form: 8-K · Filed: Jun 18, 2025 · CIK: 1279704
| Field | Detail |
|---|---|
| Company | Cellectar Biosciences, Inc. (CLRB) |
| Form Type | 8-K |
| Filed Date | Jun 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, corporate-events, financials
TL;DR
Cellectar filed an 8-K on 6/18/25 - check for updates.
AI Summary
Cellectar Biosciences, Inc. filed an 8-K on June 18, 2025, reporting other events and financial statements. The company, formerly known as Novelos Therapeutics, Inc. and Common Horizons Inc., is incorporated in Delaware and headquartered in Florham Park, NJ.
Why It Matters
This filing provides an update on Cellectar Biosciences' corporate events and financial status, which is crucial for investors to assess the company's current standing.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically reports significant events but doesn't inherently signal high risk on its own.
Key Players & Entities
- Cellectar Biosciences, Inc. (company) — Registrant
- June 18, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- Florham Park, NJ (location) — Address of principal executive offices
- Novelos Therapeutics, Inc. (company) — Former company name
- Common Horizons Inc (company) — Former company name
FAQ
What specific 'Other Events' are being reported in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
What is the significance of the 'Financial Statements and Exhibits' being filed?
This indicates that updated financial information and supporting documents are being provided to the SEC, which is important for investors to review.
When was Cellectar Biosciences, Inc. incorporated?
Cellectar Biosciences, Inc. was incorporated in Delaware.
What is the principal executive office address for Cellectar Biosciences, Inc.?
The principal executive offices are located at 100 Campus Drive, Florham Park, NJ, 07932.
What were the previous names of Cellectar Biosciences, Inc.?
The company was formerly known as NOVELOS THERAPEUTICS, INC. and COMMON HORIZONS INC.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 18, 2025 regarding Cellectar Biosciences, Inc. (CLRB).